Antibody Citations
OriGene products have been used extensively by scientists worldwide to improve their research efficiency. For your reference, we have collected a representation of citations for selected OriGene products and posted them at this site.
Search citations by gene symbols or target names
Here are some of the recent papers making use of OriGene products by fellow researchers.
| Target | Research Paper | Journal | Product | SKU |
|---|---|---|---|---|
| Grin3b | Persistent Neuroadaptations in the Nucleus Accumbens Core Accompany Incubation of Methamphetamine Craving in Male and Female Rats | eNeuro, 2023 Feb | Antibody | TA328844 |
| GRK2 | Efficient homing of antibody-secreting cells to the bone marrow requires RNA-binding protein ZFP36L1 | The Journal of experimental medicine, 2021 Mar | Antibody | AP21131PU-N |
| GRM2 | Blockade of soluble epoxide hydrolase attenuates post-ischemic neuronal hyperexcitation and confers resilience against stroke with TrkB activation | Sci Rep, 2018 Jan | Antibody | TA326000 |
| GRO beta | Interaction of periodontitis and orthodontic tooth movement-an in vitro and in vivo study | Clinical oral investigations, 2021 May | Antibody | TA328332 |
| GRPR | 64 Cu-SAR-Bombesin PET-CT Imaging in the Staging of Estrogen/Progesterone Receptor Positive, HER2 Negative Metastatic Breast Cancer Patients: Safety, Dosimetry and Feasibility in a Phase I Trial | Pharmaceuticals, 2022 Jun | Antibody | TA316872 |
| GSC | Spatiotemporal clustering of the epigenome reveals rules of dynamic gene regulation | Genome Res., Feb 2013; 23: 352 - 364., 2013 Feb | Antibody | TA500087 |
| GSC | Spatiotemporal clustering of the epigenome reveals rules of dynamic gene regulation | Genome Res., Feb 2013; 23: 352 - 364., 2013 Feb | Antibody | TA500087S |
| GSDMC | Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor ß Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation | PLoS ONE, 2016 Nov | Antibody | TA315616 |
| GSK3A | Drug repurposing studies of PARP inhibitors as a new therapy for inherited retinal degeneration | Cell. Mol. Life Sci., 2019 Aug | Antibody | AP02551PU-S |
| GST | Cezanne promoted autophagy through PIK3C3 stabilization and PIK3C2A transcription in lung adenocarcinoma | Cell Death Discovery, 2023 Aug | Antibody | TA150101 |
| GST | Integrated proteomics and metabolomics analysis of lumbar in a rat model of osteoporosis treated with Gushukang capsules | BMC Complementary Medicine and Therapies, 2022 Dec | Antibody | TA150033 |
| GST | Lysine demethylase KDM1A promotes cell growth via FKBP8–BCL2 axis in hepatocellular carcinoma | The Journal of Biological Chemistry, 2022 Aug | Antibody | TA150101 |
| GST | LRP6 promotes invasion and metastasis of colorectal cancer through cytoskeleton dynamics | Oncotarget, 2017 Dec | Antibody | TA150101 |
| GST | FMNL2 destabilises COMMD10 to activate NF-κB pathway in invasion and metastasis of colorectal cancer | Br. J. Cancer, 2017 Oct | Antibody | TA150033 |
| GST | Rtt101-Mms1-Mms22 coordinates replication-coupled sister chromatid cohesion and nucleosome assembly | EMBO Rep., 2017 Aug | Antibody | TA150101 |
| GST | A type Ⅲ effector NleF from EHEC inhibits epithelial inflammatory cell death by targeting caspase-4 | BioMed Research International, 2017 Apr | Antibody | TA150101 |
| GST | The Salmonella effector SteA binds phosphatidylinositol 4-phosphate for subcellular targeting within host cells | Cell Microbiol., 2016 Jul | Antibody | AB9929-200 |
| GST | The Salmonella effector SteA binds phosphatidylinositol 4-phosphate for subcellular targeting within host cells | Cell Microbiol., 2016 Jul | Antibody | AB9929-500 |
| GST | Arl13b and the exocyst interact synergistically in ciliogenesis | Mol Biol Cell., 2015 Nov | Antibody | AB9919-200 |
| GST | Arl13b and the exocyst interact synergistically in ciliogenesis | Mol Biol Cell., 2015 Nov | Antibody | AB9919-500 |
| GST | Arl13b and the exocyst interact synergistically in ciliogenesis | Mol Biol Cell., 2015 Nov | Antibody | AB9019-200 |
| GST | Arl13b and the exocyst interact synergistically in ciliogenesis | Mol Biol Cell., 2015 Nov | Antibody | AB9019-500 |
| GSTP1 | Integrated hepatic transcriptome and proteome analysis of mice with high-fat diet-induced nonalcoholic fatty liver disease | J. Nutr. Biochem., 2010 Mar | Antibody | AP08769PU-N |
| GTP cyclohydrolase 1 | Exercise training augments neuronal nitric oxide synthase dimerization in the paraventricular nucleus of rats with chronic heart failure | Nitric Oxide, 2019 Mar | Antibody | TA323417 |
| GTSE1 | A liquid-like spindle domain promotes acentrosomal spindle assembly in mammalian oocytes | Science (New York, N.Y.), 2019 Jul | Antibody | TA367587 |
| GYPA | Expansion and differentiation of ex vivo cultured erythroblasts in scalable stirred bioreactors | Biotechnology and Bioengineering, 2022 Aug | Antibody | DM066R |
| GYPA | Extracellular vesicles derived from Plasmodium-infected and non-infected red blood cells as targeted drug delivery vehicles | Int J Pharm, 2020 Jul | Antibody | SM3141P |
| GYPA | An ImmunoPEGliposome for Targeted Antimalarial Combination Therapy at the Nanoscale | Pharmaceutics, 2019 Jul | Antibody | SM3141P |
| GYPA | ImmunoPEGliposomes for the targeted delivery of novel lipophilic drugs to red blood cells in a falciparum malaria murine model | Biomaterials, 2018 Aug | Antibody | SM3141P |
| GYPA | Structure-activity relationship of new antimalarial 1-aryl-3-susbtituted propanol derivatives: Synthesis, preliminary toxicity profiling, parasite life cycle stage studies, target exploration, and targeted delivery | European Journal of Medicinal Chemistry, 2018 Apr | Antibody | SM3141P |
| GYPA | Immunoliposome-mediated drug delivery to Plasmodium-infected and non-infected red blood cells as a dual therapeutic/prophylactic antimalarial strategy | J Control Release, 2015 May | Antibody | SM3141P |
| GYPA | Immunoliposome-mediated drug delivery to Plasmodium-infected and non-infected red blood cells as a dual therapeutic/prophylactic antimalarial strategy | J Control Release, 2015 May | Antibody | AP05437PU-N |
| GYS1 | GEN-27, a Newly Synthetic Isoflavonoid, Inhibits the Proliferation of Colon Cancer Cells in Inflammation Microenvironment by Suppressing NF-κB Pathway | Mediators Inflamm., 2016 Feb | Antibody | AP06146PU-N |
| GYS1 | A Novel Mouse Model that Recapitulates Adult onset Glycogenosis type 4 | Hum. Mol. Genet., 2015 Sep | Antibody | TA300820 |
| GYS1 | Generation of a novel mouse model that recapitulates early and adult onset glycogenosis type IV | Hum. Mol. Genet., Sep 2011; 10.1093/hmg/ddr371., 2011 Oct | Antibody | TA300820 |
| GZMB | Natural Killer Cell Phenotype and Functionality Affected by Exposure to Extracellular Survivin and Lymphoma-Derived Exosomes | International Journal of Molecular Sciences, 2021 Jan | Antibody | DM1208 |
| GZMB | Natural Killer Cell Phenotype and Functionality Affected by Exposure to Extracellular Survivin and Lymphoma-Derived Exosomes | International journal of molecular sciences, 2021 Jan | Antibody | TA505930 |
| GZMB | Identification of drug-specific public TCR driving severe cutaneous adverse reactions | Nat Commun, 2019 Aug | Antibody | TA312131 |
| GZMK | Interleukin-4 suppresses the cytotoxic potential of in vitro generated, adaptive regulatory CD4 T cells by down-regulation of granzyme B | Immunology, 2018 Dec | Antibody | DM1209 |
| GZMK | Detection of soluble human granzyme K in vitro and in vivo | Eur. J. Immunol., 2014 Oct | Antibody | DM1213 |
| GZMK | Detection of soluble human granzyme K in vitro and in vivo | Eur. J. Immunol., 2014 Oct | Antibody | DM1214 |
| GZMK | Differential expression of human granzymes A, B, and K in natural killer cells and during CD8+ T cell differentiation in peripheral blood | Eur. J. Immunol., 2005 Sep | Antibody | DM1209 |
| H2-D1 | CD95-dependent bystander lysis caused by CD4+ T helper 1 effectors | J. Immunol., 2018 Oct | Antibody | AM08080PU-N |
| H2-D1 | In vivo priming of two distinct antitumor effector populations: the role of MHC class I expression | J. Exp. Med., 2018 Apr | Antibody | AM08080PU-N |
| H2-D1 | The specific binding of peptide ligand to Ld class I major histocompatibility complex molecules determines their antigenic structure | J. Exp. Med., 2018 Feb | Antibody | AM08080PU-N |
| H2-D1 | In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL | Cancer Gene Ther., 2017 Mar | Antibody | AM08080PU-N |
| H2-D1 | Beta 2-microglobulin is not required for cell surface expression of the murine class I histocompatibility antigen H-2Db or of a truncated H-2Db | Proc. Natl. Acad. Sci. U.S.A., 1986 Oct | Antibody | AM08080PU-N |
| H2-D1 | Specific recognition of the product of a transferred major histocompatibility complex gene by cytotoxic T lymphocytes | Proc. Natl. Acad. Sci. U.S.A., 1982 Jun | Antibody | AM08080PU-N |
| H2-D1 | Monoclonal antibodies to mouse MHC antigens. II. Antibodies to the H-2Ld antigen, the products of a third polymorphic locus of the mouse major histocompatibility complex | J. Immunol., 1981 Dec | Antibody | AM08080PU-N |
| H2-D1 | Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression | J. Immunol., 1981 Jan | Antibody | AM08080PU-N |
Germany
Japan
United Kingdom
China